Amundi’s Tandem Diabetes Care TNDM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$176K Sell
11,652
-963
-8% -$16.8K ﹤0.01% 1989
2026
Q1
$242K Sell
12,615
-16,830
-57% -$366K ﹤0.01% 1819
2025
Q4
$647K Buy
29,445
+18,423
+167% +$332K ﹤0.01% 1386
2025
Q3
$165K Hold
11,022
﹤0.01% 1559
2025
Q2
$188K Sell
11,022
-14,162
-56% -$280K ﹤0.01% 1620
2025
Q1
$445K Sell
25,184
-44,687
-64% -$1.31M ﹤0.01% 1517
2024
Q4
$2.62M Buy
69,871
+20,970
+43% +$709K ﹤0.01% 1119
2024
Q3
$1.95M Buy
48,901
+532
+1% +$22.6K ﹤0.01% 1164
2024
Q2
$1.93M Sell
48,369
-19,979
-29% -$834K ﹤0.01% 1114
2024
Q1
$2.11M Buy
+68,348
New +$1.83M ﹤0.01% 1145
2023
Q3
Sell
-73,446
Closed -$1.81M 2064
2023
Q2
$1.81M Sell
73,446
-107,875
-59% -$3.47M ﹤0.01% 1177
2023
Q1
$7.46M Buy
181,321
+26,326
+17% +$1.09M ﹤0.01% 911
2022
Q4
$6.51M Buy
154,995
+21,420
+16% +$970K ﹤0.01% 945
2022
Q3
$6.97M Sell
133,575
-8,645
-6% -$474K ﹤0.01% 900
2022
Q2
$7.62M Sell
142,220
-11,699
-8% -$960K 0.01% 830
2022
Q1
$18.9M Buy
153,919
+24,390
+19% +$2.85M 0.01% 682
2021
Q4
$16.1M Sell
129,529
-274,033
-68% -$37M 0.01% 733
2021
Q3
$48.2M Sell
403,562
-73,952
-15% -$8.15M 0.03% 456
2021
Q2
$46.5M Buy
+477,514
New +$42.6M 0.03% 459

Other funds holding TNDM

Amundi's TNDM Position: Q2 2026 in Review

Amundi reduced its Tandem Diabetes Care (TNDM) stake by 7.6% in Q2 2026, selling an estimated $16.8K and leaving 11,652 shares worth $176K. The position accounts for ﹤0.01% of the portfolio, ranked #1989.

Amundi first reported a position in TNDM in Q2 2021 and has held it in 19 quarters since. The position peaked at $48.2M in Q3 2021. 274 funds tracked by Wall St. Rank hold TNDM as of Q2 2026.

  • Amundi held 11,652 shares of Tandem Diabetes Care worth $176K as of Q2 2026.
  • Amundi sold 963 Tandem Diabetes Care shares in Q2 2026, an estimated $16.8K.
  • Tandem Diabetes Care made up ﹤0.01% of Amundi's portfolio in Q2 2026, its #1989 holding.
  • Amundi first reported a position in Tandem Diabetes Care in Q2 2021 and has held it in 19 quarters since.
  • Amundi's Tandem Diabetes Care position peaked at $48.2M in Q3 2021.
  • 274 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2026.

Based on Amundi's 13F filing for Q2 2026, filed 11 Aug 2026.